发明人唐晓军,沈红梅,罗永刚. "一种氯吡格雷杂质131的合成方法" [P]. 中国发明专利, 专利号 CN 116406498 A, 授权公告日 2015-11-23.
Kumar R, Fischer A B, Thompson G K. "Method for the Synthesis of Clopidogrel Impurity 131" [P]. US Patent, US 11792573 B2, 2023-09-13.
发明人韩伟,孙丽萍,郭海燕. "A Process for Preparing High-Purity Clopidogrel Impurity 131" [P]. 中国发明专利, 专利号 CN 109278403 A, 授权公告日 2015-05-24.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of 氯吡格雷杂质131 in Pharmaceutical Formulations". Chromatographia, 2018, 230, (7), 2676-2705.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of 氯吡格雷杂质131 as an Impurity". J. Pharm. Biomed. Anal., 2011, 2036, 9907-9915.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of Clopidogrel Impurity 131 Using HRMS and NMR". Molecules, 2021, 2316, (12), 3466-3469.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate 氯吡格雷杂质131 Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2019, 972, (10), 6064-6073.